156 related articles for article (PubMed ID: 22125840)
1. Old and new immunohistochemical markers for the diagnosis of gastrointestinal stromal tumors.
González-Cámpora R; Delgado MD; Amate AH; Gallardo SP; León MS; Beltrán AL
Anal Quant Cytol Histol; 2011 Feb; 33(1):1-11. PubMed ID: 22125840
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.
Liegl B; Hornick JL; Corless CL; Fletcher CD
Am J Surg Pathol; 2009 Mar; 33(3):437-46. PubMed ID: 19011564
[TBL] [Abstract][Full Text] [Related]
3. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
Miettinen M; Wang ZF; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT).
Miettinen M; Sobin LH; Sarlomo-Rikala M
Mod Pathol; 2000 Oct; 13(10):1134-42. PubMed ID: 11048809
[TBL] [Abstract][Full Text] [Related]
5. DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours.
Novelli M; Rossi S; Rodriguez-Justo M; Taniere P; Seddon B; Toffolatti L; Sartor C; Hogendoorn PC; Sciot R; Van Glabbeke M; Verweij J; Blay JY; Hohenberger P; Flanagan A; Dei Tos AP
Histopathology; 2010 Aug; 57(2):259-70. PubMed ID: 20716168
[TBL] [Abstract][Full Text] [Related]
6. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors.
Espinosa I; Lee CH; Kim MK; Rouse BT; Subramanian S; Montgomery K; Varma S; Corless CL; Heinrich MC; Smith KS; Wang Z; Rubin B; Nielsen TO; Seitz RS; Ross DT; West RB; Cleary ML; van de Rijn M
Am J Surg Pathol; 2008 Feb; 32(2):210-8. PubMed ID: 18223323
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases.
Miettinen M; Monihan JM; Sarlomo-Rikala M; Kovatich AJ; Carr NJ; Emory TS; Sobin LH
Am J Surg Pathol; 1999 Sep; 23(9):1109-18. PubMed ID: 10478672
[TBL] [Abstract][Full Text] [Related]
8. Strong PDGFRA positivity is seen in GISTs but not in other intra-abdominal mesenchymal tumors: Immunohistochemical and mutational analyses.
Peterson MR; Piao Z; Weidner N; Yi ES
Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):390-6. PubMed ID: 17122634
[TBL] [Abstract][Full Text] [Related]
9. PKCtheta expression in gastrointestinal stromal tumor.
Kim KM; Kang DW; Moon WS; Park JB; Park CK; Sohn JH; Jeong JS; Cho MY; Jin SY; Choi JS; Kang DY
Mod Pathol; 2006 Nov; 19(11):1480-6. PubMed ID: 16892012
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathological and immunohistochemical analysis of gastrointestinal, urinary and perineal stromal tumors].
Yu GH; Ni XH; Qian F; Chen LH
Zhonghua Bing Li Xue Za Zhi; 2003 Apr; 32(2):111-4. PubMed ID: 12839670
[TBL] [Abstract][Full Text] [Related]
11. [Gastrointestinal stromal tumor: a clinicopathological study of 74 cases].
Yang QC; Ji XH; Shen Y; Han F; Zhang XJ; Liu HB
Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):6-10. PubMed ID: 15796874
[TBL] [Abstract][Full Text] [Related]
12. Changing phenotype of gastrointestinal stromal tumours under imatinib mesylate treatment: a potential diagnostic pitfall.
Pauwels P; Debiec-Rychter M; Stul M; De Wever I; Van Oosterom AT; Sciot R
Histopathology; 2005 Jul; 47(1):41-7. PubMed ID: 15982322
[TBL] [Abstract][Full Text] [Related]
13. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status.
West RB; Corless CL; Chen X; Rubin BP; Subramanian S; Montgomery K; Zhu S; Ball CA; Nielsen TO; Patel R; Goldblum JR; Brown PO; Heinrich MC; van de Rijn M
Am J Pathol; 2004 Jul; 165(1):107-13. PubMed ID: 15215166
[TBL] [Abstract][Full Text] [Related]
14. Use of tissue microarrays and immunohistochemistry to standardize the diagnosis of gastrointestinal stromal tumors.
Ogino J; Asanuma H; Sakurai S; Matsuno Y; Miyokawa N; Yamashiro K; Fukazawa Y; Muraoka S; Iwaki Y; Kondo N; Hasegawa T
Pathol Int; 2010 Nov; 60(11):707-13. PubMed ID: 20946519
[TBL] [Abstract][Full Text] [Related]
15. [Gastrointestinal stromal tumors: definition, histological, immunohistochemical, and molecular features, and diagnostic strategy].
Coindre JM; Emile JF; Monges G; Ranchère-Vince D; Scoazec JY
Ann Pathol; 2005 Oct; 25(5):358-85; quiz 357. PubMed ID: 16498290
[TBL] [Abstract][Full Text] [Related]
16. [Expression of CD117, CD34, SMA, S-100 protein, Vim and desmin in patients with gastrointestinal stromal tumors].
Liu J; Liu YH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):438-40. PubMed ID: 18359707
[TBL] [Abstract][Full Text] [Related]
17. Prediction of KIT mutation in gastrointestinal stromal tumors by the immunoprofile of the tumor cells.
Chou CC; Chou MJ; Tzen CY
J Formos Med Assoc; 2010 Jan; 109(1):25-31. PubMed ID: 20123583
[TBL] [Abstract][Full Text] [Related]
18. [Gastrointestinal stromal tumors (GISTs): clinical and pathological features].
Kovács M; Nagy P; Pák G; Fehér J
Orv Hetil; 2005 Jun; 146(26):1375-81. PubMed ID: 16052979
[TBL] [Abstract][Full Text] [Related]
19. [CD117 contribution in the diagnosic of mesenchymal tumors of the digestive tract].
Khadija B; Saadia B; Ines C; Sami K; Mohamed J; Zina C; Nidhammeddine K; Mohamed MZ; Slim H
Tunis Med; 2005 Nov; 83(11):669-71. PubMed ID: 16422363
[TBL] [Abstract][Full Text] [Related]
20. An immunohistochemical and molecular study of gastrointestinal stromal tumours.
Teong YT; Teo ST; Tan LP; Wu BQ; Peh SC
Med J Malaysia; 2006 Dec; 61(5):526-33. PubMed ID: 17623951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
